5.28
price up icon2.92%   0.15
after-market Handel nachbörslich: 5.36 0.08 +1.52%
loading
Schlusskurs vom Vortag:
$5.13
Offen:
$5.13
24-Stunden-Volumen:
4.52M
Relative Volume:
2.78
Marktkapitalisierung:
$489.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.33%
1M Leistung:
+11.16%
6M Leistung:
+35.04%
1J Leistung:
+247.37%
1-Tages-Spanne:
Value
$4.955
$5.47
1-Wochen-Bereich:
Value
$4.78
$5.50
52-Wochen-Spanne:
Value
$1.48
$5.98

Atyr Pharma Inc Stock (ATYR) Company Profile

Name
Firmenname
Atyr Pharma Inc
Name
Telefon
(858) 731-8389
Name
Adresse
10240 SORRENTO VALLEY ROAD, SAN DIEGO
Name
Mitarbeiter
59
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ATYR's Discussions on Twitter

Vergleichen Sie ATYR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATYR
Atyr Pharma Inc
5.28 489.52M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-18 Eingeleitet Leerink Partners Outperform
2025-01-06 Eingeleitet Cantor Fitzgerald Overweight
2024-10-04 Eingeleitet Wells Fargo Overweight
2024-09-05 Eingeleitet Jefferies Buy
2023-07-05 Herabstufung Oppenheimer Outperform → Perform
2021-10-12 Eingeleitet RBC Capital Mkts Outperform
2021-09-21 Eingeleitet Piper Sandler Overweight
2021-05-10 Eingeleitet Laidlaw Buy
2020-08-17 Hochstufung H.C. Wainwright Neutral → Buy
2020-03-04 Eingeleitet ROTH Capital Buy
2020-03-02 Eingeleitet Oppenheimer Outperform
2018-02-14 Herabstufung JP Morgan Neutral → Underweight
2017-09-07 Eingeleitet Piper Jaffray Overweight
2016-12-13 Herabstufung JP Morgan Overweight → Neutral
2015-12-16 Eingeleitet Citigroup Neutral
2015-06-01 Eingeleitet Citigroup Buy
2015-06-01 Eingeleitet JP Morgan Overweight
Alle ansehen

Atyr Pharma Inc Aktie (ATYR) Neueste Nachrichten

pulisher
Jun 17, 2025

With 70% ownership, aTyr Pharma, Inc. (NASDAQ:ATYR) boasts of strong institutional backing - Yahoo Finance

Jun 17, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Makes New $330,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR) - MarketBeat

Jun 16, 2025
pulisher
Jun 14, 2025

Cantor Fitzgerald Comments on Atyr PHARMA FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Takes Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

91,224 Shares in Atyr PHARMA INC (NASDAQ:ATYR) Bought by Bank of America Corp DE - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Atyr PHARMA (NASDAQ:ATYR) Stock Price Up 6.1%Here's Why - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Estimates Atyr PHARMA FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

aTyr: Promising Data But Cash May Be An Issue (NASDAQ:ATYR) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Invests $96,000 in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Makes New $44,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Makes New Investment in Atyr PHARMA INC (NASDAQ:ATYR) - MarketBeat

Jun 07, 2025
pulisher
Jun 05, 2025

H.C. Wainwright reaffirms aTyr Pharma stock with a $35 price target - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Atyr PHARMA (NASDAQ:ATYR) Receives Buy Rating from HC Wainwright - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

aTyr Pharma reports positive interim results for SSc-ILD treatment By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

aTyr Pharma Announces Findings from Interim Analysis of - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

ATYR Stock Update: HC Wainwright Reiterates 'Buy' Rating with $3 - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

ATYR Stock Update: HC Wainwright Reiterates 'Buy' Rating with $35 Price Target | ATYR Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

aTyr Pharma reports positive interim results for SSc-ILD treatment - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

aTyr Pharma (ATYR) Reports Promising Interim Results for Efzofitimod | ATYR Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Takes $1.33 Million Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Breakthrough: aTyr's New Drug Shows Promising Results in 75% of Severe Scleroderma Patients - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

aTyr Pharma (ATYR) Scheduled for Key Presentation in New York | - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

aTyr Pharma (ATYR) Scheduled for Key Presentation in New York | ATYR Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

aTyr Pharma stock soars to 52-week high of $4.66 By Investing.com - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Atyr PHARMA INC (NASDAQ:ATYR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Jun 02, 2025
pulisher
May 31, 2025

182,625 Shares in Atyr PHARMA INC (NASDAQ:ATYR) Bought by Northern Trust Corp - Defense World

May 31, 2025
pulisher
May 29, 2025

Woodline Partners LP Purchases New Position in Atyr PHARMA INC (NASDAQ:ATYR) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Atyr PHARMA INC (NASDAQ:ATYR) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

May 29, 2025
pulisher
May 27, 2025

High Growth Tech Stocks in the US to Watch This May 2025 - Yahoo Finance

May 27, 2025
pulisher
May 26, 2025

Group One Trading LLC Takes $26,000 Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 26, 2025
pulisher
May 26, 2025

Jane Street Group LLC Invests $720,000 in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 26, 2025
pulisher
May 24, 2025

aTyr Pharma’s SWOT analysis: biotech firm’s stock poised for potential breakthrough - Investing.com India

May 24, 2025
pulisher
May 24, 2025

aTyr Pharma’s SWOT analysis: biotech firm’s stock poised for potential breakthrough By Investing.com - Investing.com South Africa

May 24, 2025
pulisher
May 21, 2025

aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential - Insider Monkey

May 21, 2025
pulisher
May 20, 2025

aTyr Pharma to Present at Upcoming Investor Conferences - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

aTyr Pharma Announces Triple Conference Schedule: RBC, Jefferies, and Piper Sandler Healthcare Events Coming Up - Stock Titan

May 20, 2025
pulisher
May 19, 2025

aTyr Pharma (ATYR) Highlights Efzofitimod Research at ATS 2025 | ATYR Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

aTyr Pharma (ATYR) Highlights Efzofitimod Research at ATS 2025 | - GuruFocus

May 19, 2025
pulisher
May 19, 2025

aTyr Pharma (ATYR) Receives Steady 'Buy' Rating from HC Wainwright | ATYR Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Such Is The Power Of Atyr Pharma Inc (NASDAQ: ATYR) - Stocksregister

May 19, 2025
pulisher
May 19, 2025

aTyr Pharma Presents Three Posters on Efzofitimod at the - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Breakthrough Phase 3 Trial Reveals 158,900 Patients Could Benefit from New Sarcoidosis Treatment - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Buys Shares of 44,310 Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 19, 2025
pulisher
May 19, 2025

aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference - The Manila Times

May 19, 2025
pulisher
May 17, 2025

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rul - GuruFocus

May 17, 2025
pulisher
May 16, 2025

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 16, 2025
pulisher
May 16, 2025

ATyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Makes New $881,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 16, 2025

Finanzdaten der Atyr Pharma Inc-Aktie (ATYR)

Es liegen keine Finanzdaten für Atyr Pharma Inc (ATYR) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Atyr Pharma Inc-Aktie (ATYR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Broadfoot Jill Marie
Chief Financial Officer
Feb 04 '25
Sale
3.78
1,254
4,740
31,763
DENYES NANCY
General Counsel
Feb 04 '25
Sale
3.78
899
3,398
26,555
SCHIMMEL PAUL
Director
Jul 24 '24
Buy
1.93
52,300
101,038
413,023
SCHIMMEL PAUL
Director
Jul 22 '24
Buy
1.74
41,052
71,500
354,075
SCHIMMEL PAUL
Director
Jul 23 '24
Buy
1.82
6,648
12,075
360,723
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):